Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 399 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Testosterone Clear all

Conditions: Hypogonadism, Male
Interventions: Testosterone Cypionate Injection 200 mg/mL; Drug
Lead sponsor: Azurity Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 6
States / cities: Birmingham, Alabama • DeLand, Florida • Hialeah, Florida + 3 more

Conditions: Cachexia
Interventions: Deuterated Water, Testosterone enanthate, Placebo to match testosterone enanthate; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 60 Years to 75 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue, Prostate Carcinoma Metastatic in the Bone, Stage IV Prostate Adenocarcinoma AJCC v7
Interventions: Abiraterone Acetate, Androgen deprivation therapy, Cabazitaxel, Prednisone; Drug
Lead sponsor: ECOG-ACRIN Cancer Research Group; Network
Eligibility: 18 Years and older · Male only
Enrollment: 223 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 665
States / cities: Fairbanks, Alaska • Goodyear, Arizona • Kingman, Arizona + 437 more

Conditions: Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Interventions: Testosterone Undecanoate, Enzalutamide; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Baltimore, Maryland • Pittsburgh, Pennsylvania

Conditions: Prostate Cancer
Interventions: Testosterone injection, Etoposide; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypogonadism, Low Testosterone
Interventions: Androxal (enclomiphene citrate), Testim (topical testosterone); Drug
Lead sponsor: Repros Therapeutics Inc.; Industry
Eligibility: 21 Years to 65 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 8
States / cities: Garden Grove, California • Sacramento, California • San Diego, California + 2 more

Conditions: Klinefelter Syndrome, XXY Syndrome
Interventions: Testosterone gel 1%, Placebo gel; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 8 Years to 18 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Male Infertility, Low Sperm Quality, Low Testosterone, Low Energy, Low Libido
Interventions: WeNatal For Him Supplement; Dietary Supplement
Lead sponsor: WeNatal; Industry
Eligibility: 30 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Men With Low Testosterone Levels
Interventions: Testosterone Enanthate, Placebo; Drug · Other
Lead sponsor: Leonard S. Marks, M.D.; Other
Eligibility: 50 Years and older · Male only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Culver City, California

Conditions: Hypogonadism
Interventions: Androderm®; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 41
States / cities: Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 37 more

Conditions: Adult Male Hypogonadism
Interventions: Testosterone Gel (FE 999093); Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 16
States / cities: Huntsville, Alabama • Newport Beach, California • San Diego, California + 13 more

Conditions: Spinal Cord Injury
Interventions: Testosterone and LPWS, Testosterone and standard NMES; Device · Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Infertility
Interventions: Enclomiphene citrate, Placebo; Drug · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 35 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Cord Injury
Interventions: Resistance Training and Testosterone Patches, Testosterone Patches; Device · Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Hypogonadism
Interventions: Testosterone; Drug
Lead sponsor: Acrux DDS Pty Ltd; Industry
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 7
States / cities: Birmingham, Alabama • La Mesa, California • Torrance, California + 4 more

Conditions: Pain, Hypogonadism
Interventions: AndroGel, Placebo; Drug · Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Apnea, Obstructive, Sleep Apnea, Hypotestosteronism
Interventions: Not listed
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years to 70 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 2
States / cities: Burlington, Massachusetts • Peabody, Massachusetts

Conditions: Aqueous Tear Deficiency, Meibomian Gland Dysfunction of Bilateral Eyes (Disorder)
Interventions: Testosterone gel 4.5%, Vehicle gel; Drug
Lead sponsor: Southern California College of Optometry at Marshall B. Ketchum University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Fullerton, California

Conditions: Prostate Cancer
Interventions: therapeutic testosterone; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy Volunteers
Interventions: Axiron; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Daytona Beach, Florida

Conditions: Hypogonadism
Interventions: Testosterone MD-Lotion; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 11
States / cities: Birmingham, Alabama • Tuscon, Arizona • Burbank, California + 8 more

Conditions: Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP)
Interventions: Testosterone Gel (1%); Drug
Lead sponsor: Solvay Pharmaceuticals; Industry
Eligibility: 13 Years to 17 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 9
States / cities: Birmingham, Alabama • Torrance, California • Jacksonville, Florida + 6 more

Conditions: Contraception
Interventions: Acyline, Testosterone Gel, Depo-Medroxyprogesterone; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer, Microsatellite Instability
Interventions: Durvalumab, Laboratory Biomarker Analysis; Biological · Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Search by objective public record fields.

Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer

A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203

Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome

A Clinical Trial to Evaluate the Effects of a Supplement on Markers of Male Fertility

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel

Testosterone and Long Pulse Stimulation After SCI

Androxal in Male Infertility

Resistance Training and Testosterone After Spinal Cord Injury

Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males

Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception

Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome

Eyelid Androgen Treatment in Dry Eye

Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy

A Study of Axiron® in Healthy Participants

A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations

Pharmacokinetic Evaluation of Testosterone Gel (1%)

Male Hormonal Contraceptive Development-ACY-5

Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer